BeOne Medicines (NasdaqGS:BGNE) FY Conference Transcript
BeOne Medicines (NasdaqGS:BGNE) FY Conference September 08, 2025 01:50 PM ET Company ParticipantsMark Lanasa - SVP & Chief Medical Officer - Solid TumorsMatt Shaulis - General Manager - North AmericaConference Call ParticipantsSean Laaman - Research Analyst - Biotechnology Small & MidcapSean LaamanGood afternoon, everyone, and welcome to the Morgan Stanley Global Healthcare Conference. I'm Sean M. Laaman, Head of U.S. Mid-Cap Biotech Equity Research here at the firm. Before we begin, for important disclosur ...